Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Protocol for Patients With Newly-Diagnosed Non-Metastatic Osteosarcoma - A POG/CCG Pilot Intergroup Study

Trial Profile

Protocol for Patients With Newly-Diagnosed Non-Metastatic Osteosarcoma - A POG/CCG Pilot Intergroup Study

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 21 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cisplatin (Primary) ; Dexrazoxane (Primary) ; Doxorubicin (Primary) ; Etoposide (Primary) ; Ifosfamide (Primary) ; Methotrexate (Primary)
  • Indications Osteosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2021 Results of pooled analysis (n=1308) assessing long-term outcomes among children newly diagnosed with cancer who were treated in dexrazoxane-containing clinical trials (P9404, P9425, P9426, DFCI 95-01 and P9754), published in the Cancer.
    • 31 May 2020 Results (N=173), subgroup analysis of data pooled from 5 randomized trials (P9404, P9425, P9426, DFCI 95-01 and P9754) assessing cardiac function in long-term survivors , plus a matched group of osteosarcoma survivors treated with Doxorubicin alone, presented at the 56th Annual Meeting of the American Society of Clinical Oncology
    • 16 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top